Plasma phospholipid metabolic profiling and biomarkers of mouse IgA nephropathy

Metabolomics

Volumn 2, Issue 2, 2006, Pages 95-104

  Jia, Lewen ^a,b   Wang, Chang ^a   Kong, Hongwei ^a   Cai, Zongwei ^c   Xu, Guowang ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

^c HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

Author keywords

High performance liquid chromatography; IgA nephropathy; Intercellular adhesion molecule 1; Mass spectrometry; Metabonomics; Phospholipid

Indexed keywords

EID: 33746885119     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-006-0025-3     Document Type: Article

References (48)

1. Alessenko A.V. and Burlakova E.B. (2002). Functional role of phospholipids in the nuclear events. Bioelectrochemistry 58:13-21
2. Arrizabalaga P., Sole M., Ascaso C. and Quinto L.I. (1997) Intercellular adhesion molecule-1 mediated interactions and leucocyte infiltration in IgA nephropathy. Nephrol. Dial. Transplant. 12:2258-2262
3. Arrizabalaga P., Sole M. and Abellana R. (2003) Tubular and interstitial expression of ICAM-1 as a marker of renal injury in IgA nephropathy. Am. J. Nephrology 23:121-128
4. 1H-NMR-based metabonomics. J. Nat. Med. 8:1439-1444
5. D'amico G. (1987) The Commonest glomerulonephritis in the world IgA nephropathy. Q. J. Med. 64:709-723
6. Dolones C.D., Gray A.P. and Lucocq J.M. (2005) Probing phosphoinositide functions in signaling and membrane trafficking. Trends Cell Biol. 15:259-267
7. Ebbels T.M-D., Antti H., Bollard M.E. et al. (2003) Improved analysis of multivariate data by variable stability scaling: Application to NMR-based metabolic profiling. Anal. Chim. Acta 490:265-276
8. Emancipator S.N., Gallo G.R. and Lamm M.E. (1983) Experimental IgA nephropathy induced by oral immunization. J. Exp. Med. 157:572-582
9. Eriksson, L., Johansson, E., Kettaneh-Wold, H. and Wold, S. (1999). Introduction to multi- and megavariate analysis using projection methods (PCA & PLS-DA). Umetrics Inc, Box7960, SE90719 Umeå Sweden, pp. 267-296
10. Fiehn O. (2002) Metabolomics: The link between genotypes and phenotypes. Plant Mol. Biol. 48:155-171
11. Freeman R., Goodacre R., Sisson P.R., Magee J.G., Ward A.C., Lightfoot N.F. (1994) Rapid identification of species within the mycobacterium-tuberculosis complex by artificial neural-network analysis of pyrolysis mass-spectra. J. Med. Microbiol. 40:170-173
12. Fukui M., Nakamura T., Ebihara I. (1992) ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520
13. Ghosh S., Strum J.C., Bell R.M. (1997) Lipid biochemistry: Functions of glycerolipids and sphigolipids in cellular signling. FASEB J. 11:45-50
14. Goodacre R., Rooney P.J. and Kell D.S. (1998) Discrimination between methicillin-resistant and methicillin-susceptible staphylococcus aureus using pyrolysis mass spectrometry and artificial neural networks. J. Antimicrob. Chemother. 41:27-34
15. Goodacre R., Vaidyanathan S., Bianchi G. and Kell D.B. (2002) Metabolic profiling using infusion electrospray ionization mass spectrometry for the characterization of olive oils. Analyst 127:1457-1462
16. Halket J.M., Przyborowska A., Stein S.E., Mallard W.G., Down S. and Chalmers R.A. (1999) Deconvolution gas chromatography/mass spectrometry of urinary organic acids-potential for pattern recognition and automated identification of metabolic disorders. Rapid Commun. Mass Spectrom. 13:279-284
17. Han X., Gross R.W. (1995) Structural determination of picomole amounts of phospholipids via electrospray ionization tandem mass spectrometry. J. Am. Soc. Mass Spectrom. 6:1202-1210
18. Hiroko H., Yoichi Y., Haruhisa O., Naoya K., Masatoshi M. and Susumu Y. (1999) Evaluation of serum lipid abnormalities in chronic nephritis. Kidney Int. 56:S147-S149
19. Hujjbregts R.P., Topalof L. and Bankaitis V.A. (2000) Lipid metabolism and regulation of membrane trafficking. Traffic 1:195-202
20. Ibels L.S., Gyori A.Z., Caterson R.J. et al. (1997) Primary IgA nephropathy: Natural history and factors of importance in the progression of renal impairment. Kidney Int. 52(Suppl 61): 67-70
21. Idborg-Bjorkman H., Edlund P.O., Kvalheim O.M., Schuppe-koistinen I. and Jacobsson S.P. (2003) Screening of biomarkers in rat urine using LC/ electrospray ionization-MS and two-way data analysis. Anal. Chem. 75:4784-4792
22. Jackson S.N., Hay-Yan J.W. and Woods A.S. (2005) Direct tissue analysis of phospholipids in rat brain using MALDI-TOFMS and MALDI-ion mobility-TOFMS. J. Am. Soc. Mass Spectrom. 16:133-138
23. Katafuchi R., Oh Y., Hori K., Komota T., Yanase T. and Ikeda K. (1994) An important role of glomerular segmental lesions on progression of IgA nephropathy: A multivariate analysis. Clin. Nephrol. 41:191-198
24. 13C NMR spectroscopy of urine for metabonomic studies. Anal. Chem. 74:4588-4593
25. Lemmon M.A. (2003) Phosphoinositide recognition domains. Traffic 4:201-213
26. Lindon J.C., Nicholson J.K., Holmes E. et al. (2003) Contemporary issues in toxicology. The role of metabonomics in toxicology and evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187:137-146
27. Lynch J.J., Ferro T.J., Blumenslock F.A. (1990) Increased endothelial albumin permeability mediated by protein kinase C activation. J. Clin. Invest. 85:1991
28. Mills G.B. and Moolenaar W.H. (2003) The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer. 3:582-591
29. Nicholson J.K., Connelly J., Lindon J.C. and Holmes E. (2002) Metabonomics: A platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1:153-161
30. Nicholson J.K. and Wilson I.D. (2003) Understanding 'global' systems biology: Metabonomics and the continuum of metabolism. Nat. Rev. Drug Discov. 2:668-677
31. Ohno I., Hosoya T., Gomi H., Ichida K., Okabe H. and Hikita M. (2001) Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87:333-339
32. Pavlidis P., Ramaswami M. and Tanouye M.A. (1994) The Drosophila easily shocked gene: A mutation in a phospholipids synthetic pathway causes seizure, neuronal. Cell 79:23-33
33. Plumb R.S., Stumpf C.L., Gorenstein M.V. et al. (2002) Metabonomics: The use of electrospray mass spectrometry.coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Commun Mass Spectrom. 16:1991-1996
34. Plumb R.S., Stumpf C.L., Granger J.H., Castro-Perez J., Haselden J.N. and Dear G.J. (2003) Use of liquid chromatography/time-of-flight mass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids. Rapid Commun. Mass Spectrom. 17:2632-2638
35. Rasooly L. and Pestka J.J. (1994) Polyclonal autoreactive IgA increase and mesangial deposition during vomitoxin-induced IgA nephropathy in the Balb/c mouse. Fd. Chem. Toxicol. 32:329-336
36. Rhee S.G. et al. (2001) Regulation of phosphoinositide-specific phospholipase C. Annu. Rev. Biochem. 70:281-312
37. Roberts L.J. (2002) II. Lipids as regulators of cell function. Cell Mol. Life Sci. 59:727-728
38. Sengoelge G., Fodinger M., Skoupy S. et al. (1998) Endothelial cell adhesion molecule and PMNL response to inflammatory stimuli and AGE-modified fibronection. Kidney Int. 54:1637-1651
39. Spector A.A. and Yorek M.A. (1985) Membrane lipid composition and cellular function. J. Lipid. Res. 26:1015-1035
40. Taylor J., King R.D., Altmann T. and Fiehn O. (2002) Application of metabolomics to plant genotype discrimination using statistics and machine learning. Bioinformatics 18: S241-S248
41. Uran S., Larsen A., Jacobsen P.B. and Skotland T. (2001) Sensitive and specific liquid chromatographic-tamdem mass spectrometric assay for dihydroergotamine and its major metabolite in human plasma. J. Chromatogr. B. 768:265-275
42. Wang C., Xie S.G., Yang J., Yang Q. and Xu G.W. (2004) Structural identification of human blood phospholipids using liquid chromatography/ quadrupole-linear ion trap Mass Spectrometry. Anal. Chim. Acta. 525:1-10
43. Wenk M.R. (2005) The emerging field of lipidomics. Nat. Rev. Drug Discov. 4:594-610
44. Winson M.K., Goodacre R., Timmins E.M. et al. (1997) Diffuse reflectance absorbance spectroscopy taking in chemometrics (DRASTIC).A hyperspectral FT-IR-based approach to rapid screening for metabolite overproduction. Anal. Chim. Acta 348:273-282
45. Yorek, M.A. (1993). Phospholipids Handbook, Cevc, G.(Ed.), Marcel Dekker, Inc., New York, 745 pp
46. Yukawa S., Hibino A., Maeda T., Mimura K. and Yukawa A. (1995) Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients. Nephrol. Dial. Transplant. 10 (Suppl 3):1-3
47. Yang J., Xu G., Zheng Y., Kong H., Pang T., Lv S., Yang Q. (2004) Diagnosis of liver cancer using HPLC-based metabonomics in the aim to avoid the false-positive result from hepatitis and hepatocirrhosis diseases. J. Chromatogr. B. 813:59-65
48. Yang J., Xu G., Zheng Y., Kong H., Wang C., Zhao X., Pang T. (2005) Strategy for metabonomics research based on high performance liquid chromatography and LC/MS/MS. J. Chromatogr. A 1084:214-221